<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34887288</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1757-790X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>12</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Dec</Month>
              <Day>09</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMJ case reports</Title>
          <ISOAbbreviation>BMJ Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Primary Evans syndrome in an adult man.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">e243051</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/bcr-2021-243051</ELocationID>
        <Abstract>
          <AbstractText>Evans syndrome (ES) is a simultaneous or subsequent development of two haematological disorders, autoimmune haemolytic anaemia (AIHA) and immune thrombocytopenia (ITP). It can be primary (idiopathic) or secondary (associated with an underlying disease). Primary Evans is a diagnosis of exclusion and has a poorer prognosis than AIHA or ITP alone. We present a 55-year-old man who presented with weakness and lethargy and was diagnosed to be suffering from primary ES.</AbstractText>
          <CopyrightInformation>© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Makharia</LastName>
            <ForeName>Archita</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>General Medicine, Dr Sampurnanand Medical College, Jodhpur, India archita.makharia@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lakhotia</LastName>
            <ForeName>Manoj</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>General Medicine, Dr Sampurnanand Medical College, Jodhpur, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roy</LastName>
            <ForeName>Brateen</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>General Medicine, Dr Sampurnanand Medical College, Jodhpur, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMJ Case Rep</MedlineTA>
        <NlmUniqueID>101526291</NlmUniqueID>
        <ISSNLinking>1757-790X</ISSNLinking>
      </MedlineJournalInfo>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C536380">Evans Syndrome</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000744" MajorTopicYN="Y">Anemia, Hemolytic, Autoimmune</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016553" MajorTopicYN="Y">Purpura, Thrombocytopenic, Idiopathic</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013921" MajorTopicYN="Y">Thrombocytopenia</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">general practice/family medicine</Keyword>
        <Keyword MajorTopicYN="N">haematology (incl blood transfusion)</Keyword>
        <Keyword MajorTopicYN="N">surgery</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>12</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>10</Day>
          <Hour>5</Hour>
          <Minute>56</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34887288</ArticleId>
        <ArticleId IdType="pmc">PMC8663103</ArticleId>
        <ArticleId IdType="doi">10.1136/bcr-2021-243051</ArticleId>
        <ArticleId IdType="pii">14/12/e243051</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Audia S, Grienay N, Mounier M, et al. . Evans’ Syndrome: From Diagnosis to Treatment. J Clin Med
2020;9:3851. 10.3390/jcm9123851</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm9123851</ArticleId>
            <ArticleId IdType="pmc">PMC7759819</ArticleId>
            <ArticleId IdType="pubmed">33260979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barcellini W, Fattizzo B, Zaninoni A, et al. . Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood
2014;124:2930–6. 10.1182/blood-2014-06-583021</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2014-06-583021</ArticleId>
            <ArticleId IdType="pubmed">25232059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michel M, Chanet V, Dechartres A, et al. . The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases. Blood
2009;114:3167–72. 10.1182/blood-2009-04-215368</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2009-04-215368</ArticleId>
            <ArticleId IdType="pubmed">19638626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aladjidi N, Fernandes H, Leblanc T, et al. . Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort. Front Pediatr
2015;3:79. 10.3389/fped.2015.00079</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fped.2015.00079</ArticleId>
            <ArticleId IdType="pmc">PMC4586429</ArticleId>
            <ArticleId IdType="pubmed">26484337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hansen DL, Möller S, Andersen K, et al. . Evans syndrome in adults - incidence, prevalence, and survival in a nationwide cohort. Am J Hematol
2019;94:1081–90. 10.1002/ajh.25574</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajh.25574</ArticleId>
            <ArticleId IdType="pubmed">31292991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaime-Pérez JC, Aguilar-Calderón PE, Salazar-Cavazos L, et al. . Evans syndrome: clinical perspectives, biological insights and treatment modalities. J Blood Med
2018;9:171–84. 10.2147/JBM.S176144</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/JBM.S176144</ArticleId>
            <ArticleId IdType="pmc">PMC6190623</ArticleId>
            <ArticleId IdType="pubmed">30349415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brodsky RA. How I treat paroxysmal nocturnal hemoglobinuria. Blood
2021;137:1304–9. 10.1182/blood.2019003812</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood.2019003812</ArticleId>
            <ArticleId IdType="pmc">PMC7955407</ArticleId>
            <ArticleId IdType="pubmed">33512400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fattizzo B, Michel M, Giannotta JA, et al. . Evans’ Syndrome in Adults: An Observational Multicentre Study. Blood
2020;136:27–8. 10.1182/blood-2020-136900</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2020-136900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barcellini W, Zaninoni A, Giannotta JA, et al. . New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy Stage 1. J Clin Med
2020;9:3859. 10.3390/jcm9123859</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm9123859</ArticleId>
            <ArticleId IdType="pmc">PMC7759854</ArticleId>
            <ArticleId IdType="pubmed">33261023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barcellini W, Fattizzo B. Clinical Applications of Haemolytic Markers in theDifferential Diagnosis and Management of Haemolytic Anaemia. Dis Markers2015
2015;635670.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4706896</ArticleId>
            <ArticleId IdType="pubmed">26819490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birgens H, Frederiksen H, Hasselbalch HC, et al. . A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia. Br J Haematol
2013;163:393–9. 10.1111/bjh.12541</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bjh.12541</ArticleId>
            <ArticleId IdType="pubmed">23981017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michel M, Terriou L, Roudot-Thoraval F, et al. . A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study). Am J Hematol
2017;92:23–7. 10.1002/ajh.24570</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajh.24570</ArticleId>
            <ArticleId IdType="pubmed">27696475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barcellini W, Fattizzo B. How I treat warm autoimmune hemolytic anemia. Blood
2021;137:1283–94. 10.1182/blood.2019003808</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood.2019003808</ArticleId>
            <ArticleId IdType="pubmed">33512406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jäger U, Barcellini W, Broome CM, et al. . Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev
2020;41:100648. 10.1016/j.blre.2019.100648</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.blre.2019.100648</ArticleId>
            <ArticleId IdType="pubmed">31839434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Provan D, Arnold DM, Bussel JB, et al. . Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv
2019;3:3780–817. 10.1182/bloodadvances.2019000812</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/bloodadvances.2019000812</ArticleId>
            <ArticleId IdType="pmc">PMC6880896</ArticleId>
            <ArticleId IdType="pubmed">31770441</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
